HANNOVER, Germany--(BUSINESS WIRE)--BIOTECHNICA 2008 will be staging the first separate meeting-place for pharmaceutical biotechnology. This year’s event will see the debut of the new platform “Science to Market” staged by the European Association of Pharma Biotechnology (EAPB), which represents joint cooperation with European BioPerspectives, a conference organized by DECHEMA (Society for Chemical Engineering and Biotechnology). Stephan Kühne, Board member of Deutsche Messe AG, believes: “The collaboration with BIOTECHNICA will add considerably to the promotion of research projects dedicated to pharmaceutical biotechnology.” The President of the EAPB, Wieland Wolf, adds: “Science to Market will provide an important impetus to the dialogue between science and the business community. The event offers European research institutes and universities an ideal platform for presenting their R&D efforts and an opportunity to establish international contacts with industrial companies with a view to promoting potentially commercial products.”
